ACCOUNTS - Final Accounts


Caseware UK (AP4) 2014.0.91 2014.0.91 2016-03-31The principal activity of the company continued to be that of retail chemists and druggists. The principal activity of the company continued to be that of retail chemists and druggists2016-03-31The principal activity of the company continued to be that of retail chemists and druggists. The principal activity of the company continued to be that of retail chemists and druggiststruetruetruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsetruefalse2015-04-01 02022221 2015-04-01 2016-03-31 02022221 2014-04-01 2015-03-31 02022221 2016-03-31 02022221 2015-03-31 02022221 2014-04-01 02022221 1 2015-04-01 2016-03-31 02022221 1 2014-04-01 2015-03-31 02022221 d:ExplicitlyIdentifiedAsNon-exceptional 2015-04-01 2016-03-31 02022221 d:ExplicitlyIdentifiedAsNon-exceptional 2014-04-01 2015-03-31 02022221 e:CompanySecretary1 2015-04-01 2016-03-31 02022221 e:Director1 2015-04-01 2016-03-31 02022221 e:Director1 2016-03-31 02022221 e:Director2 2015-04-01 2016-03-31 02022221 e:Director3 2015-04-01 2016-03-31 02022221 e:Director4 2015-04-01 2016-03-31 02022221 e:Director4 2016-03-31 02022221 e:Director5 2015-04-01 2016-03-31 02022221 e:Director5 2016-03-31 02022221 e:RegisteredOffice 2015-04-01 2016-03-31 02022221 d:Buildings d:ShortLeaseholdAssets 2015-04-01 2016-03-31 02022221 d:Buildings d:ShortLeaseholdAssets 2015-03-31 02022221 d:FurnitureFittings 2015-04-01 2016-03-31 02022221 d:FurnitureFittings 2016-03-31 02022221 d:FurnitureFittings 2015-03-31 02022221 d:FurnitureFittings d:OwnedOrFreeholdAssets 2015-04-01 2016-03-31 02022221 d:OwnedOrFreeholdAssets 2015-04-01 2016-03-31 02022221 d:PatentsTrademarksLicencesConcessionsSimilar 2015-04-01 2016-03-31 02022221 d:PatentsTrademarksLicencesConcessionsSimilar 2016-03-31 02022221 d:PatentsTrademarksLicencesConcessionsSimilar 2015-03-31 02022221 d:CurrentFinancialInstruments 2016-03-31 02022221 d:CurrentFinancialInstruments 2015-03-31 02022221 d:CurrentFinancialInstruments d:WithinOneYear 2016-03-31 02022221 d:CurrentFinancialInstruments d:WithinOneYear 2015-03-31 02022221 f:UnitedKingdom 2015-04-01 2016-03-31 02022221 f:UnitedKingdom 2014-04-01 2015-03-31 02022221 d:UKTax 2015-04-01 2016-03-31 02022221 d:UKTax 2014-04-01 2015-03-31 02022221 d:RetainedEarningsAccumulatedLosses 2015-04-01 2016-03-31 02022221 d:RetainedEarningsAccumulatedLosses 2016-03-31 02022221 d:RetainedEarningsAccumulatedLosses 2014-04-01 2015-03-31 02022221 d:RetainedEarningsAccumulatedLosses 2015-03-31 02022221 d:RetainedEarningsAccumulatedLosses 2014-04-01 02022221 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2016-03-31 02022221 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2015-03-31 02022221 e:OrdinaryShareClass1 2015-04-01 2016-03-31 02022221 e:OrdinaryShareClass1 2016-03-31 02022221 e:FRS102 2015-04-01 2016-03-31 02022221 e:Audited 2015-04-01 2016-03-31 02022221 e:FullAccounts 2015-04-01 2016-03-31 02022221 e:PrivateLimitedCompanyLtd 2015-04-01 2016-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02022221









TAYZANA LIMITED









DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2016

 
TAYZANA LIMITED
 
 
COMPANY INFORMATION


Directors
Mr J C Patel (resigned 1 June 2015)
Mr T Mohamedbhai 
Miss H Patel 
Mr K C Patel Jnr (appointed 1 June 2015, resigned 16 July 2016)
Mr J C Patel Jnr (appointed 1 June 2015)




Company secretary
Mr A R Patel



Registered number
02022221



Registered office
2 Peterwood Way

Croydon

Surrey

CR0 4UQ




Independent auditors
KPMG LLP, Statutory Auditor
Chartered Accountant

1 Forest Gate

Brighton Road

Crawley

RH11 9PT





 
TAYZANA LIMITED
 

CONTENTS



Page
Directors' Report
1 - 2
Independent Auditors' Report
3 - 4
Profit and Loss Account
5
Statement of Comprehensive Income
5
Balance Sheet
6
Statement of Changes in Equity
7
Notes to the Financial Statements
8 - 25


 
TAYZANA LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2016

The Directors present their report and the financial statements for the year ended 31 March 2016.

Principal activity

The principal activity of the company continued to be that of retail chemists and druggists.

Directors' responsibilities statement

The Directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period. In preparing these financial statements, the Directors are required to:

·select suitable accounting policies for the Company's financial statements and then apply them consistently;

·make judgments and accounting estimates that are reasonable and prudent;

·state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

·prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Directors

The Directors who served during the year were:

Mr J C Patel (resigned 1 June 2015)
Mr T Mohamedbhai 
Miss H Patel 
Mr K C Patel Jnr (appointed 1 June 2015, resigned 16 July 2016)
Mr J C Patel Jnr (appointed 1 June 2015)

Disclosure of information to auditor

Each of the persons who are Directors at the time when this Directors' Report is approved has confirmed that:
 
·so far as the Director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

·the Director has taken all the steps that ought to have been taken as a Director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Page 1

 
TAYZANA LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2016

Auditor

Under section 487(2) of the Companies Act 2006KPMG LLP, Statutory Auditor will be deemed to have been reappointed as auditors 28 days after these financial statements were sent to members or 28 days after the latest date prescribed for filing the accounts with the registrar, whichever is earlier.

Small Companies Note

In preparing this report, the Directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 
 



Mr J C Patel Jnr
Director

Date: 22 December 2016

2 Peterwood Way
Croydon
Surrey
CR0 4UQ

Page 2

 
 
 
INDEPENDENT AUDITORS' REPORT TO THE SHAREHOLDERS OF
TAYZANA LIMITED

We have audited the financial statements of Tayzana Limited for the year ended 31 March 2016, set out on pages 5 to 25. The relevant financial reporting framework that has been applied in their preparation is the Companies Act 2006 and the United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'.


This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.


Respective responsibilities of Directors and Auditors
 

As explained more fully in the Directors' Responsibilities Statement on page 1, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board’s Ethical Standards for Auditors.


Scope of the audit of the financial statements
 

A description of the scope of an audit of financial statements is provided on the Financial Reporting Council's website at www.frc.org.uk/auditscopeukprivate.


Opinion on financial statements
 

In our opinion the financial statements:


·give a true and fair view of the state of the Company's affairs as at 31 March 2016 and of its profit for the year then ended;

·have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

·have been prepared in accordance with the requirements of the Companies Act 2006.



Opinion on other matter prescribed by the Companies Act 2006
 

In our opinion the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with those financial statements.


Page 3

 
 
 
INDEPENDENT AUDITORS' REPORT TO THE SHAREHOLDERS OF TAYZANA LIMITED (CONTINUED)

Matters on which we are required to report by exception
 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
 

·adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

·the financial statements are not in agreement with the accounting records and returns; or

·certain disclosures of directors' remuneration specified by law are not made; or
 
·we have not received all the information and explanations we require for our audit; or
 
·the Directors were not entitled to take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Directors' Report.






Timothy Rush (Senior Statutory Auditor)
  
for and on behalf of
KPMG LLP, Statutory Auditor
 
Chartered Accountant
  
1 Forest Gate
Brighton Road
Crawley
RH11 9PT

22 December 2016
Page 4

 
TAYZANA LIMITED
 
 
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2016

2016
2015
Note
£000
£000

  

Turnover
 4 
4,219
4,223

Cost of sales
  
(2,778)
(2,934)

Gross profit
  
1,441
1,289

Administrative expenses
  
(1,181)
(1,073)

Other operating income
 5 
13
16

Operating profit
 6 
273
232

Interest payable and similar charges
 9 
(2)
(10)

Profit before tax
  
271
222

Tax on profit on ordinary activities
 10 
(53)
(49)

Profit for the year
  
218
173

There were no recognised gains and losses for 2016 or 2015 other than those included in the profit and loss account.


STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2016

2016
2015
Note
£000
£000


Profit for the financial year

  

218
173


Other comprehensive income
  
-
-

Total comprehensive income for the year
  
218
173
The notes on pages 8 to 25 form part of these financial statements.

Page 5

 
TAYZANA LIMITED
REGISTERED NUMBER: 02022221

BALANCE SHEET
AS AT 31 MARCH 2016

2016
2015
Note
£000
£000

Fixed assets
  

Intangible assets
 12 
1,212
1,224

Tangible assets
 13 
116
81

  
1,328
1,305

Current assets
  

Stocks
 14 
195
219

Debtors: amounts falling due within one year
 15 
375
456

Cash at bank and in hand
 16 
55
7

  
625
682

Creditors: amounts falling due within one year
 17 
(1,029)
(1,077)

Net current liabilities
  
 
 
(404)
 
 
(395)

Total assets less current liabilities
  
924
910

Provisions for liabilities
  

Deferred tax
 19 
(31)
(31)

Net assets
  
893
879


Capital and reserves
  

Called up share capital 
 20 
-
-

Profit and loss account
 21 
893
879

  
893
879


The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Mr J C Patel Jnr
Director


Date: 22 December 2016
The notes on pages 8 to 25 form part of these financial statements.

Page 6

 
TAYZANA LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2016


Called up share capital
Profit and loss account
Total equity


£000
£000
£000

At 1 April 2015
-
879
879


Comprehensive income for the year

Profit for the year

-
218
218


Other comprehensive income for the year
-
-
-


Total comprehensive income for the year
-
218
218

Dividends: Equity capital
-
(204)
(204)


Total transactions with owners
-
(204)
(204)


At 31 March 2016
-
893
893


STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2015


Called up share capital
Profit and loss account
Total equity


£000
£000
£000

At 1 April 2014
-
960
960


Comprehensive income for the year

Profit for the year

-
173
173


Other comprehensive income for the year
-
-
-


Total comprehensive income for the year
-
173
173

Dividends: Equity capital
-
(254)
(254)


Total transactions with owners
-
(254)
(254)


At 31 March 2015
-
879
879


The notes on pages 8 to 25 form part of these financial statements.

Page 7

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

1.


General information

Tayzana Limited (the “Company”) is a private company limited by shares and incorporated and domiciled in the United Kingdom. The address of the registered office is given on company information page. The nature of the company's operations and its principal activities are set out in the director's report on pages 1 to 2.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

Information on the impact of first-time adoption of FRS 102 is given in note 26.

The transitional exemptions available in FRS 102 where applicable are stated in relevant accounting policies.
The functional currency of Tayzana Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates. The financial statements are also presented in pounds sterling and rounded to nearest £'000.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Financial reporting standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
·the requirements of Section 7 Statement of Cash Flows;
·the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
·the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Day Lewis Plc as at 31 March 2016 and these financial statements may be obtained from 2 Peterwood Way, Croydon, Surrey, CR0 4UQ.

 
2.3

Going concern

The financial statements have been prepared on a going concern basis as the parent undertaking, Day Lewis PLC, has formally indicated its intention to continue to provide financial support to the Company to meet its obligations as they fall due for the foreseeable future, and for a period of at least 12 months from the date of approval of these financial statements. The directors have no reason to believe that the parent company will not be in a position to provide the support referred to above and, accordingly, they have prepared the financial statements on a going concern basis.

Page 8

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

2.Accounting policies (continued)

  
2.4
Turnover

Turnover comprises revenue recognised by the Company in respect of goods and services supplied services during the year, exclusive of Value Added Tax and trade discounts.

 
2.5

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed five years.

 The estimated useful lives range as follows:

Retail pharmacy licence
-

100

years
 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives. 

Depreciation is provided on the following basis:

Leasehold Property
-
over the period of the lease
Fixtures, fittings and equipment
-
15% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Profit and Loss Account.

Page 9

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

2.Accounting policies (continued)

 
2.7

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to the Profit and Loss Account on a straight line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

The Company has taken advantage of the optional exemption available on transition to FRS 102 which allows lease incentives on leases entered into before the date of transition to the standard 01 April 2014 to continue to be charged over the period to the first market rent review rather than the term of the lease.

 
2.8

Operating leases: the Company as lessor

Rentals income from operating leases is credited to the Profit and Loss Account on a straight line basis over the term of the relevant lease.

Amounts paid and payable as an incentive to sign an operating lease are recognised as a reduction to income over the lease term on a straight line basis, unless another systematic basis is representative of the time pattern over which the lessor's benefit from the leased asset is diminished.

The Company has taken advantage of the optional exemption available on transition to FRS 102 which allows lease incentives on leases entered into before the date of transition to the standard 01 April 2014 to continue to be charged over the period to the first market rent review rather than the term of the lease.

 
2.9

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first outbasis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.10

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 10

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

2.Accounting policies (continued)

 
2.12

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Investments in non-convertible preference shares and in non-puttable ordinary and preference shares are measured:
·at fair value with changes recognised in the Profit and Loss Account if the shares are publicly traded or their fair value can otherwise be measured reliably;
·at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.13

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 11

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

2.Accounting policies (continued)

 
2.14

Finance costs

Finance costs are charged to the Profit and Loss Account over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.15

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. Dividends on shares recognised as liabilities are recognised as expenses and classified within interest payable.

 
2.16

Borrowing costs

All borrowing costs are recognised in the Profit and Loss Account in the year in which they are incurred.

 
2.17

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to the Profit and Loss Account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the Balance Sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.

Page 12

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

2.Accounting policies (continued)

 
2.18

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
·The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits;
·Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met; and
·Where they relate to timing differences in respect of interests in subsidiaries, associates, branches and joint ventures and the Company can control the reversal of the timing differences and such reversal is not considered probable in the foreseeable future.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Page 13

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

In the application of the company's accounting policies, which are described in note 2, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Critical judgements in applying the company's accounting policies
The following are the critical judgements, apart from those involving estimations (which are dealt with separately below), that the directors have made in the process of applying the company's accounting policies and that have the most significant effect on the amounts recognised in the financial statements.
Key source of estimation uncertainty - impairment of retail pharmacy licences
Determining whether retail pharmacy license is impaired requires an estimation of the value in use of the cash-generating units to which retail pharmacy license has been allocated. The carrying amount of retail pharmacy license at the balance sheet date was £1.2m after an impairment loss of £nil was recognised during the year 2016.
Key source of estimation uncertainty - useful life of retail pharmacy licences
The directors believe that the right for dispensing UK NHS prescriptions, being the pharmacy licence which is attached to a particular pharmacy, has a continuing value. Such rights, conferred by the Department of Health as contracts to dispense prescriptions, are not generally granted to new pharmacies in the same locality. Consequently the Directors consider that the value of retail pharmacy licences have a long life of 100 years and therefore are amortised over that period.


4.


Turnover

The whole of the turnover is attributable to be that of retail pharmacy.

Analysis of turnover by country of destination:

2016
2015
£000
£000

United Kingdom
4,219
4,223

4,219
4,223


Page 14

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

5.


Other operating income

2016
2015
£000
£000

Net rents receivable
13
16

13
16



6.


Operating profit

The operating profit is stated after charging:

2016
2015
£000
£000

Depreciation of tangible fixed assets
20
14

Amortisation of intangible assets, including goodwill
12
12

Other operating lease rentals
103
104

During the year, no Director received any emoluments (2015 - £NIL).


7.


Auditors' remuneration

2016
2015
£000
£000


Fees payable to the Company's auditor and its associates for the audit of the Company's annual accounts
2
2


Page 15

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

8.


Employees

Staff costs were as follows:


2016
2015
£000
£000

Wages and salaries
655
604

Social security costs
152
100

807
704


The average monthly number of employees, including the Directors, during the year was as follows:


        2016
        2015
            No.
            No.






Distribution and sales
23
35


Administrative and pharmacists
6
5

29
40


9.


Interest payable and similar charges

2016
2015
£000
£000


Bank interest payable
2
10

2
10

Page 16

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

10.


Taxation


2016
2015
£000
£000

Corporation tax


Current tax on profits for the year
53
45


Total current tax
53
45

Deferred tax


Origination and reversal of timing differences
3
4

Changes to tax rates
(3)
-

Total deferred tax
-
4


Taxation on profit on ordinary activities
53
49

Factors affecting tax charge for the year

The tax assessed for the year is lower than (2015 - higher than) the standard rate of corporation tax in the UK of 20% (2015 - 21%). The differences are explained below:

2016
2015
£000
£000


Profit on ordinary activities before tax
271
222


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 20% (2015 - 21%)
54
47

Effects of:


Non-tax deductible amortisation of goodwill and impairment
2
2

Other tax adjustments
(3)
-

Total tax charge for the year
53
49

Page 17

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016
 
10.Taxation (continued)


Factors that may affect future tax charges


Reductions in the UK corporation tax rate from 20% to 19% (effective from 1 April 2017) and 18% (effective from 1 April 2020) were substantively enacted on 26 October 2015. A further reduction to the UK corporation tax rate was announced in the 2016 Budget to further reduce the tax rate to 17% from 18% (to be effective from 1 April 2020).  This will reduce the company's future current tax charge accordingly. The deferred tax liability on pharmacy licences will reduce by £1.5K.
The deferred tax liability at the balance sheet date has been calculated based on the rate of 18% substantively enacted at the balance sheet date.

11.


Dividends

2016
2015
£000
£000


Dividends paid
204
254

204
254



12.


Intangible assets




Retail pharmacy licences

£000



Cost


At 1 April 2015
1,236



At 31 March 2016

1,236



Amortisation


At 1 April 2015
12


Charge for period
12



At 31 March 2016

24



Net book value



At 31 March 2016
1,212



At 31 March 2015
1,224

Page 18

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016


13.


Tangible fixed assets





Leasehold Property
Fixtures and fittings
Total

£000
£000
£000



Cost or valuation


At 1 April 2015
51
388
439


Additions
-
55
55


Disposals
(51)
-
(51)



At 31 March 2016

-
443
443



Depreciation


At 1 April 2015
51
307
358


Charge for period
-
20
20


Disposals
(51)
-
(51)



At 31 March 2016

-
327
327



Net book value



At 31 March 2016
-
116
116



At 31 March 2015
-
81
81


14.


Stocks

2016
2015
£000
£000

Finished goods and goods for resale
195
219

195
219


Stock recognised in cost of sales during the year as an expense was  £2,778K (2015 - £2,934K).


 

Page 19

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

15.


Debtors


2016
2015
£000
£000


Trade debtors
223
306

Amounts owed by group undertakings
-
9

Other debtors
124
113

Prepayments and accrued income
28
28

375
456



16.


Cash and cash equivalents

2016
2015
£000
£000

Cash at bank and in hand
55
7

Less: bank overdrafts
(228)
(492)

(173)
(485)



17.


Creditors: Amounts falling due within one year

2016
2015
£000
£000

Bank overdrafts
228
492

Trade creditors
403
380

Amounts owed to group undertakings
259
103

Corporation tax
-
21

Other creditors
114
51

Accruals and deferred income
25
30

1,029
1,077


Page 20

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

18.


Financial instruments

2016
2015
£000
£000

Financial assets


Financial assets measured at fair value
55
7

55
7





19.


Deferred taxation




2016
2015


£000

£000






At beginning of year
(31)
(27)


Charged to profit or loss
-
(4)



At end of year
(31)
(31)

The provision for deferred taxation is made up as follows:

2016
2015
£000
£000


Accelerated capital allowances
(3)
(3)

Deferred tax on retail pharmacy licences
(28)
(28)

(31)
(31)


20.


Share capital

2016
2015
£
£
Shares classified as equity

Allotted, called up and fully paid



100 Ordinary shares of £1 each
100
100

Page 21

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

21.


Reserves

Profit and loss account

The profit and loss reserve represents cumulative profits or losses, including dividends paid and other adjustments.


22.


Contingent liabilities

The company is a party to intra-group cross guarantees in respect of bank borrowing within the group
- Unlimited inter-company guarantees supported by legal charges over various properties and other respective associated assets.


23.


Commitments under operating leases

At 31 March 2016 the Company had future minimum lease payments under non-cancellable operating leases as follows:

2016
2015
£000
£000


Not later than 1 year
79
77

Later than 1 year and not later than 5 years
406
364

Later than 5 years
2,881
2,956

3,366
3,397

Page 22

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

24.


Related party transactions

During the year the company made purchases totalling £1,244,923 (2015: £1,088,667) from and made sales totalling £84,458 (2015: £283,668) to Day Lewis Medical Limited, a fellow subsidiary of the company's parent company Day Lewis Plc. As at 31 March 2016 the company owed £165,302 (2015: £100,015) to Day Lewis Medical Limited.
During the year the company was recharged £6,415 (2015: £28,149) worth of expenses paid by Day Lewis Chemists Limited, a fellow subsidiary of the company's parent company Day Lewis Plc. £8,809 (2015: £2,418) worth of expenses paid by the company on behalf of Day Lewis Chemists Limited. As at 31 March 2016 the company owed £385 (2015: £2,779) to Day Lewis Chemists Limited.
£1,159,208 (2015: £969,101) worth of expenses paid by the Day Lewis Plc, a parent company on behalf of the company. The company recharged £434,984 (2015: £277,311) worth of expenses paid on behalf of the Day Lewis Plc. As at 31 March 2016 the company owed £88,341 (2015: £9,358 owed by) to Day Lewis Plc.
The company recharged £2,172 (2015: £1,486) worth of expenses paid on behalf of ABC Drug Stores Limited, a fellow subsidiary of the company's parent company Day Lewis Plc . £6,583 (2015: £8,562) worth of expenses paid by ABC Drug Stores Limited on behalf of the company. As at 31 March 2016 the company owed £5,329 (2015: £918) to ABC Drug Stores Limited.
During the year, the company purchased goods totalling £3,033 (2015: £1,717) from Swingward Limited. The executors of the Kirit Patel Estate has material interest in the company. At the year end the balance outstanding to Swingward Limited was £349 (2015: £252).


24.


Related party transactions (continued)

During the year, the company carried out the following transactions with extended related parties:
Rent of £22,800 (2015: £22,800) was paid in respect of a property occupied by the company in which the directors Mr J C Patel and Mr T Mohamadbhai have a material interest. As at 31 March 2016 the company owed £nil (2015: £nil).


25.


Controlling party

The company's immediate parent company is Day Lewis plc, a company registered in England and Wales.
It prepares group accounts which are available at Day Lewis House, 2 Peterwood Way, Croydon, Surrey CR0 4UQ.
The ultimate parent company is Day Lewis Holdings Limited, a company registered in Cyprus and controlled by the executors of the Kirit Patel Estate.
Copies of the ultimate parent and of its group financial statements are not publicly available.

Page 23

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

26.


First time adoption of FRS 102

The Company transitioned to FRS 102 from previously extant UK GAAP as at 1 April 2014. There were no changes to the balance sheet at the date of transition. The impact of the transition to FRS 102 is as follows:

As previously stated
31 March
2015
Effect of transition
31 March
2015
FRS 102
(as restated)
31 March
2015
Note
£000
£000
£000

Fixed assets
 1 
1,317
(12)
1,305

Current assets
  
682
-
682

Creditors: amounts falling due within one year
  
(1,077)
-
(1,077)

Net current liabilities
  
 
(395)
 
-
 
(395)

Total assets less current liabilities
  
 
922
 
(12)
 
910

Provisions for liabilities
  
(31)
-
(31)

Net  assets
  
 
891
 
(12)
 
879

Capital and reserves
  
891
(12)
879
Page 24

 
TAYZANA LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2016

           26.First time adoption of FRS 102 (continued)

As previously stated
31 March
2015
Effect of transition
31 March
2015
FRS 102
(as restated)
31 March
2015
Note
£000
£000
£000

Turnover
  
4,223
-
4,223

Cost of sales
  
(2,934)
-
(2,934)

  
 
1,289
 
-
 
1,289

Administrative expenses
 1 
(1,061)
(12)
(1,073)

Other operating income
  
16
-
16

Operating profit
  
 
244
 
(12)
 
232

Interest payable and similar charges
  
(10)
-
(10)

Taxation
  
(49)
-
(49)

Profit on ordinary activities after taxation and for the financial year
  
 
185
 
(12)
 
173

Explanation of changes to previously reported profit and equity:

1

Retail pharmacy licence has been amortised over estimated useful life of 100 years from transition date. This change in accounting estimate of an indefinite useful life under previous UK GAAP to its useful life under FRS102 resulted in £12K adjustment to previously reported profit & equity for the year ended 31 March 2015.

 
Page 25